((5-Bromo-2-chlorophenyl)(2-hydroxyphenyl)methanone)
- CAS
- 2556662-59-8
- Formula
- C13H8BrClO2
- MW
- 311.56 g/mol
VQ-036525
Impurity reference standards
Dapagliflozin impurities & reference standards
Characterised Dapagliflozin impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
93reference materials
2isotope-labelled
COAHPLC · NMR · MS on request
Parent API: Dapagliflozin
461432-26-8 · C21H25ClO6
(1S,2S,3R,4R,5R)-1-(4-Chloro-3-(4-ethoxybenzyl)phenyl)hexane-1,2,3,4,5,6-hexaol
- CAS
- 1938090-31-3
- Formula
- C21H27ClO7
- MW
- 426.9 g/mol
VQ-047932
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(3-(3-acetyl-4-ethoxybenzyl)-4-chlorophenyl)tetrahydro-2H-pyran
- CAS
- 2768435-31-8
- Formula
- C31H35ClO11
- MW
- 619.1 g/mol
VQ-036522
(2S,3S,4S,5R,6R)-6-(Acetoxymethyl)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-hydroxytetrahydro-2H-pyran-3,4-diyl Diacetate
- CAS
- 1415905-91-7
- Formula
- C27H31ClO9
- MW
- 535 g/mol
VQ-025177
(2S,3S,4S,5R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-5-((R)-1,2-diacetoxyethyl)tetrahydrofuran-3,4-diyl diacetate
- CAS
- 1469910-84-6
- Formula
- C29H33ClO10
- MW
- 577 g/mol
VQ-036521
(3R,4S,5S,6R)-6-((((2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-one
- CAS
- 2452300-92-2
- Formula
- C27H33ClO12
- MW
- 585 g/mol
VQ-030019
(4-Chloro-3-(4-ethoxybenzyl)phenyl)trimethylsilane
- CAS
- 2133407-73-3
- Formula
- C18H23ClOSi
- MW
- 318.9 g/mol
VQ-025166
(5-Bromo-2-chlorophenyl)(4- ethoxyphenyl)methanol
- CAS
- 1280647-32-6
- Formula
- C15H14BrClO2
- MW
- 341.62 g/mol
VQ-025173
![4-Bromo-1-chloro-2-[(2-ethoxyphenyl)methyl]benzene chemical structure](/media/structures/OJDCRWLGJWSFFT-UHFFFAOYSA-N.svg)
4-Bromo-1-chloro-2-[(2-ethoxyphenyl)methyl]benzene
- CAS
- 1830346-16-1
- Formula
- C15H14BrClO
- MW
- 325.63 g/mol
VQ-025170
Dapagliflozin 1-Bromo, 4-Chlorobenzene Impurity
- CAS
- 1629862-21-0
- Formula
- C15H14BrClO
- MW
- 325.63 g/mol
VQ-030026
Dapagliflozin 4-bromo-2-chlorobenzene Impurity
- CAS
- 2454263-77-3
- Formula
- C15H14BrClO
- MW
- 325.63 g/mol
VQ-036528
Dapagliflozin Hydroxy (Benzylic) Impurity (P.Code:2917)
- CAS
- 1204222-85-4
- Formula
- C21H25ClO7
- MW
- 424.9 g/mol
In stock
FAQs — Dapagliflozin impurities
Which Dapagliflozin impurities do you supply?
We list 93 Dapagliflozin-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Dapagliflozin impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Dapagliflozin impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Dapagliflozin impurity standards
We reply within one business day with price, pack options, lead time and documentation.